Clasp Therapeutics 查看官网 医疗健康 医疗技术 细胞工程 所属公司:Clasp Therapeutics Inc 当前融资轮次:A轮 成立日期:2020-01-01 所属地:马萨诸塞 简介:Clasp专注于开发针对每例患者免疫系统量身定制的模块化T细胞接合器,这些TCE为现货型、双特异性抗体样分子,旨在同时靶向T细胞表面的CD3蛋白与癌细胞表面的肿瘤...
Copyright © 2024 Published by Elsevier Inc. Part of special issue Transcatheter Cardiovascular Therapeutics AbstractsDownload full issue Recommended articles About ScienceDirect Remote access Advertise Contact and support Terms and conditions Privacy policy Cookies are used by this site. Cookie Settings ...
When considered as a format for therapeutics, the high heat stability of the Fv-clasp(v2) can be a great advantage because such property is critically important for antibody fragments used in immunotherapies (Friedel et al., 2015, Willuda et al., 1999). Furthermore, the SARAH domain used ...